Tải xuống
Tóm tắt
ABSTRACT
Objectives: To determine the epidemiological, clinical, paraclinical characteristics and evaluate the result in treatment of hepatoblastoma (HB) at Department of Hematology-Oncology, Children’s Hospital 2 from January 2011 to end of May 2019.
Method: Cases series study in combination of retrospective and prospective.
Results: From January 2011 to end of May 2019, there were 67 patients diagnosed with HB. The mean age at diagnosis was 22.7 ± 22.9 months with the most prevalent age group ranging from 6 months to 3 years old. The male to female ratio was 1.8/1. The most common clinical symptoms were abdominal distention and hepatomegaly, approximately 7.5% HB cases were detected accidentally by ultrasound. Nearly 60% and 80% patients presented with anemia and thrombocytosis at admission, respectively. Almost tumors were unifocal locating in the right lobe of the liver and 58.2% cases belonged to standard risk group. Assessing treatment protocol in 54 HB patients demonstrated that number of patients undergoing hepatectomy after preoperative chemotherapy accounted for 82%. The most frequent acute side effects after chemotherapy were myelotoxicity and infection. The proportion of fatal and relapsed cases was 31.5% and 12.9% respectively. Overall and event-free survival rate of the study after 3 years was 65.7% and 68.1% individually.
Conclusion: Hepatoblastoma is a rare malignant childhood disease, signficantly response to chemotherapy followed by surgery. However mortality rate is rather high compared to worldwide reasearchs. Thus development of liver transplant is necessary to improve survival rate.
Tài liệu tham khảo
Au Duong My Phung, (2008), “Hepatoblastoma: Diagnosis and treatment”, Ho Chi Minh Medical Journal, 12 (4), pp. 109.
Le Thi Thuy Dung, (2014), Study of epidemilogical, clinical features and evaluate treatment result of hepatoblastoma in pediatric patients [Master degree thesis], Ha Noi University of Medicine, pp. 52-62.
Truong Dinh Khai, (2015), Treatment result of hepatectomy in pediatric hepatoblastoma provided with prior chemotherapy [Doctor degree thesis], Ho Chi Minh University of Medicine and Pharmacy, pp. 13-20.
Devi LP KR, Handique A and Kumar M, (2014), “Hepatoblastoma-a rare liver tumor with review of literature”, J Gastrointest Cancer, 45 (1), pp. 261-264.
Linabery AM, Ross JA, (2008), “Trends in childhood cancer incidence in the U.S. (1992-2004)”, Cancer, 112 (2), pp. 416-432.
M PJaS, (2004), “Outcome and complications after resection of hepatoblastoma”, J Pediatr Surg, 39, pp. 1744-1745.
Philip Lanzkowsky JML, Jonathan D. Fish, (2016), Lanzkowsky’s Manual of Pediatric Hematology and Oncology, Academic Press,
pp. 569-576.
Spyridakis I, Kepertis C, Lampropoulos V, Mouravas V, Filippopoulos A, (2014), “Embryonal/Fetal subtype hepatoblastoma: a case report”, J Clin Diagn Res, 8 (9), pp. ND01-02.
Zhang Y, Zhang W, Tang S, Chen L, Yi Y, Zhang P, et al., (2016), “A single-center retrospective study of pediatric hepatoblastoma”, Oncol Lett, 12 (5), pp. 3919-3925.
Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, et al., (2013), “Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study”, Lancet Oncol, 14 (9), pp. 834-842.
Zsiros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, et al., (2010), “Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study”, JClin Oncol, 28 (15), pp. 2584-2590.
| Đã xuất bản | 24-01-2025 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 56 (2019) | |
| Phân mục | Nghiên cứu | |
| DOI | ||
| Từ khóa | Keywords: Hepatoblastoma, chemothearapy, surgery, liver transplant. |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2019 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế